Cargando…

Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction

Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhaliwal, Inderdeep, Mahdavian, Masoud, Asghari, Shabnam, Chun To Wong, Benson, Labelle, Rosalie, Amjadi, Kayvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198149/
https://www.ncbi.nlm.nih.gov/pubmed/28074083
http://dx.doi.org/10.1155/2016/4273480
_version_ 1782488836053401600
author Dhaliwal, Inderdeep
Mahdavian, Masoud
Asghari, Shabnam
Chun To Wong, Benson
Labelle, Rosalie
Amjadi, Kayvan
author_facet Dhaliwal, Inderdeep
Mahdavian, Masoud
Asghari, Shabnam
Chun To Wong, Benson
Labelle, Rosalie
Amjadi, Kayvan
author_sort Dhaliwal, Inderdeep
collection PubMed
description Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5 ± 1.9, BDI of 2.8 ± 0.9, and ECOG score of 3.0 ± 0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p < 0.001), QLQ-C30 dyspnea (−39, p < 0.00001), and LC13 dyspnea (−11, p < 0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE.
format Online
Article
Text
id pubmed-5198149
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51981492017-01-10 Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction Dhaliwal, Inderdeep Mahdavian, Masoud Asghari, Shabnam Chun To Wong, Benson Labelle, Rosalie Amjadi, Kayvan Can Respir J Clinical Study Objective. The PleurX® IPC system has been used extensively in the past. Over time, management of MPE with the PleurX system can be costly. The new ASEPT pleural catheter, through advantages in design, may ultimately show cost savings. The primary outcome of this study was to evaluate safety and efficacy of the ASEPT system. Method. This single centre, prospective study enrolled 50 patients with MPE, who were followed for as long as they were alive with a catheter. Quality of Life (QoL) was assessed before, at 2 weeks, and 6 weeks after ASEPT catheter insertion using the EORTC QLQ-C30 and LC13 questionnaires. Ease of catheter use and complications were reported by physician and community nurses. Results. 50 patients with MPE with a mean age of 64.5 ± 1.9, BDI of 2.8 ± 0.9, and ECOG score of 3.0 ± 0.7 were recruited. No immediate or long-term complications were reported during the study period. Compared to precatheter insertion, global health status (−18, p < 0.001), QLQ-C30 dyspnea (−39, p < 0.00001), and LC13 dyspnea (−11, p < 0.0005) significantly improved at 2 and 6 weeks after intervention. Provider surveys indicated favourable ease of use. Conclusion. The new ASEPT catheter offers a safe and effective option for the management of MPE. Hindawi Publishing Corporation 2016 2016-12-15 /pmc/articles/PMC5198149/ /pubmed/28074083 http://dx.doi.org/10.1155/2016/4273480 Text en Copyright © 2016 Inderdeep Dhaliwal et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Dhaliwal, Inderdeep
Mahdavian, Masoud
Asghari, Shabnam
Chun To Wong, Benson
Labelle, Rosalie
Amjadi, Kayvan
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_full Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_fullStr Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_full_unstemmed Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_short Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
title_sort management of malignant pleural effusion with asept® pleural catheter: quality of life, feasibility, and patient satisfaction
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198149/
https://www.ncbi.nlm.nih.gov/pubmed/28074083
http://dx.doi.org/10.1155/2016/4273480
work_keys_str_mv AT dhaliwalinderdeep managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT mahdavianmasoud managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT asgharishabnam managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT chuntowongbenson managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT labellerosalie managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction
AT amjadikayvan managementofmalignantpleuraleffusionwithaseptpleuralcatheterqualityoflifefeasibilityandpatientsatisfaction